Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 558.80 INR
Change Today -7.00 / -1.24%
Volume 935.0
HBIO On Other Exchanges
Symbol
Exchange
HBIO is not on other exchanges.
As of 7:05 AM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

hester biosciences ltd (HBIO) Snapshot

Open
556.50
Previous Close
565.80
Day High
578.00
Day Low
556.50
52 Week High
04/16/15 - 740.00
52 Week Low
05/27/14 - 93.00
Market Cap
4.8B
Average Volume 10 Days
6.3K
EPS TTM
11.11
Shares Outstanding
8.5M
EX-Date
09/18/14
P/E TM
50.3x
Dividend
2.00
Dividend Yield
0.36%
Current Stock Chart for HESTER BIOSCIENCES LTD (HBIO)

Related News

No related news articles were found.

hester biosciences ltd (HBIO) Related Businessweek News

No Related Businessweek News Found

hester biosciences ltd (HBIO) Details

Hester Biosciences Limited manufactures, markets, and exports animal vaccines and health products in India and internationally. The company offers live vaccines for avians, swine, and large animals; inactivated vaccines for avians; and health products for avians and large animals. It also provides seroprofiling services to producers for evaluating the immune response to administered vaccines and/or to obtain evidence of flock exposure to field strains; and mastitis control programs for the cattle, as well as offers diagnostics products. Hester Biosciences Limited was founded in 1987 and is based in Ahmedabad, India.

250 Employees
Last Reported Date: 08/11/11
Founded in 1987

hester biosciences ltd (HBIO) Top Compensated Officers

Chief Executive Officer, Managing Director, D...
Total Annual Compensation: 4.2M
Compensation as of Fiscal Year 2014.

hester biosciences ltd (HBIO) Key Developments

Hester Biosciences Ltd, Board Meeting, Mar 28, 2015

Hester Biosciences Ltd, Board Meeting, Mar 28, 2015. Agenda: To discuss and finalise re-appointment terms of Independent Directors.

Hester Biosciences Limited Launches its Peste Des Petits Ruminants Vaccine and Goat Pox Vaccine

Hester Biosciences Limited launched its PPR (Peste Des Petits Ruminants) vaccine and Goat Pox vaccine. With the launch of these vaccines as well as being the second large poultry vaccine manufacturer in India, Hester has positioned itself to capitalise on upcoming opportunities in the animal health care industry globally as well as in India. PPR vaccine is to be given annually to sheep and goats. PPR disease causes dysentery and death of the animal. It is therefore a disease of high economical importance worldwide. The total targeted population of sheep and goat for PPR vaccine in the world is 1,450 million. In India, the targeted population is 200 million.

Hester Biosciences Ltd Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Hester Biosciences Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales/income from operations of INR 218.83 million compared to INR 158.62 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 54.77 million compared to INR 33.81 million a year ago. Profit from ordinary activities before tax was INR 45.36 million compared to INR 25.47 million a year ago. Net profit from ordinary activities after tax was INR 33.71 million compared to INR 25.45 million a year ago. EPS before and after extraordinary items was INR 3.96 compared to INR 2.99 a year ago. For the nine months, the company reported net sales/income from operations of INR 666.76 million compared to INR 472.01 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 165.90 million compared to INR 117.95 million a year ago. Profit from ordinary activities before tax was INR 136.23 million compared to INR 90.85 million a year ago. Net profit from ordinary activities after tax was INR 104.55 million compared to INR 61.73 million a year ago. EPS before and after extraordinary items was INR 12.29 compared to INR 7.26 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HBIO:IN 558.80 INR -7.00

HBIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HBIO.
View Industry Companies
 

Industry Analysis

HBIO

Industry Average

Valuation HBIO Industry Range
Price/Earnings 36.1x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 23.0x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HESTER BIOSCIENCES LTD, please visit www.hesterbiosciences.co.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.